{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:57:16Z","timestamp":1775743036599,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.metabol.2012.09.011","type":"journal-article","created":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T19:31:43Z","timestamp":1351107103000},"page":"518-526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: A prospective matched controlled study"],"prefix":"10.1016","volume":"62","author":[{"given":"Ala I.","family":"Sharara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha M.","family":"El-Halabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola A.","family":"Ghaith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil M.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Malli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada","family":"El Hajj-Fuleihan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2012.09.011_bb0005","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/gast.2002.32978","article-title":"The burden of selected digestive diseases in the United States","volume":"122","author":"Sandler","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2012.09.011_bb0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1742-7843.2006.pto_378.x","article-title":"Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas","volume":"98","author":"Jensen","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.metabol.2012.09.011_bb0015","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1136\/bmj.e372","article-title":"Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study","volume":"344","author":"Khalili","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2012.09.011_bb0020","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.bone.2010.12.015","article-title":"Meta-analysis: risk of fractures with acid-suppressing medication","volume":"48","author":"Kwok","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2012.09.011_bb0025","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1592\/phco.28.8.951","article-title":"Proton pump inhibitor use and risk of hip fractures in patients without major risk factors","volume":"28","author":"Kaye","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.metabol.2012.09.011_bb0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00223-008-9170-1","article-title":"Acid-suppressive medications and risk of bone loss and fracture in older adults","volume":"83","author":"Yu","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.metabol.2012.09.011_bb0035","unstructured":"U.S. Food and Drug Administration. FDA drug safety communication: possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors."},{"key":"10.1016\/j.metabol.2012.09.011_bb0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2011.01.007","article-title":"Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies","volume":"124","author":"Yu","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2012.09.011_bb0045","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ajg.2011.113","article-title":"Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies","volume":"106","author":"Ngamruengphong","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.metabol.2012.09.011_bb0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM198507113130202","article-title":"Calcium absorption and achlorhydria","volume":"313","author":"Recker","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2012.09.011_bb0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/156720109787846225","article-title":"Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo","volume":"6","author":"Sheraly","year":"2009","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.metabol.2012.09.011_bb0060","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/gme.0b013e31815f8917","article-title":"Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy women","volume":"15","author":"Gass","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.metabol.2012.09.011_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.ejcn.1602056","article-title":"Low calcium and vitamin D intake in healthy children and adolescents and their correlates","volume":"59","author":"Salamoun","year":"2005","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.metabol.2012.09.011_bb0070","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/jbmr.108","article-title":"Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial","volume":"25","author":"Wright","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2012.09.011_bb0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1503\/cmaj.071330","article-title":"Use of proton pump inhibitors and risk of osteoporosis-related fractures","volume":"179","author":"Targownik","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.metabol.2012.09.011_bb0080","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2012.09.011_bb0085","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-2036.1996.d01-506.x","article-title":"Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole","volume":"10","author":"Lewis","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.metabol.2012.09.011_bb0090","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMc066308","article-title":"Proton-pump inhibitors and hypomagnesemic hypoparathyroidism","volume":"355","author":"Epstein","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2012.09.011_bb0095","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-151-10-200911170-00016","article-title":"Hypomagnesemia induced by several proton-pump inhibitors","volume":"151","author":"Broeren","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2012.09.011_bb0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF00316289","article-title":"Effects of magnesium deficiency on strength, mass, and composition of rat femur","volume":"54","author":"Kenney","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.metabol.2012.09.011_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01352010","article-title":"Effect of omeprazole, an inhibitor of H+, K(+)-ATPase, on bone resorption in humans","volume":"53","author":"Mizunashi","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.metabol.2012.09.011_bb0110","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/07315724.1995.10718522","article-title":"Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans","volume":"14","author":"Serfaty-Lacrosniere","year":"1995","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.metabol.2012.09.011_bb0115","first-page":"1376","article-title":"Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects","volume":"10","author":"Graziani","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.metabol.2012.09.011_bb0120","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000064290","article-title":"Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload. Role of gastric acid secretion.","volume":"91","author":"Graziani","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.metabol.2012.09.011_bb0125","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.amjmed.2005.02.007","article-title":"Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial","volume":"118","author":"O'Connell","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2012.09.011_bb0130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1525-1594.1998.06200.x","article-title":"Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis","volume":"22","author":"Hardy","year":"1998","journal-title":"Artif Organs"},{"key":"10.1016\/j.metabol.2012.09.011_bb0135","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/jbmr.166","article-title":"Do proton pump inhibitors decrease calcium absorption?","volume":"25","author":"Hansen","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2012.09.011_bb0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00223-001-2068-9","article-title":"Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children","volume":"71","author":"Kocsis","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.metabol.2012.09.011_bb0145","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archinternmed.2010.94","article-title":"Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative","volume":"170","author":"Gray","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.metabol.2012.09.011_bb0150","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/j.gastro.2009.11.014","article-title":"Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss","volume":"138","author":"Targownik","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2012.09.011_bb0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02556841","article-title":"Omeprazole, a specific inhibitor of H+-K+-ATPase, inhibits bone resorption in vitro","volume":"38","author":"Tuukkanen","year":"1986","journal-title":"Calcif Tissue Int"},{"issue":"Suppl. III","key":"10.1016\/j.metabol.2012.09.011_bb0160","first-page":"A110","article-title":"The effect of PPI (proton pump inhibitors) on the bone mineral density, bone microstructure and bone metabolism of rat","volume":"59","author":"Moon","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2012.09.011_bb0165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s002239900325","article-title":"Chicken parathyroid hormone gene expression in response to gastrin, omeprazole, ergocalciferol, and restricted food intake","volume":"61","author":"Gagnemo-Persson","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.metabol.2012.09.011_bb0170","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/157488608785699414","article-title":"Proton pump inhibitor therapy and osteoporosis","volume":"3","author":"Yang","year":"2008","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.metabol.2012.09.011_bb0175","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jclinepi.2003.08.015","article-title":"A case\u2013control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults","volume":"57","author":"Valuck","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.metabol.2012.09.011_bb0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/07315724.2009.10719764","article-title":"Skeletal and hormonal effects of magnesium deficiency","volume":"28","author":"Rude","year":"2009","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.metabol.2012.09.011_bb0185","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1572-0241.2003.07186.x","article-title":"Who is using chronic acid suppression therapy and why?","volume":"98","author":"Jacobson","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.metabol.2012.09.011_bb0190","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrendo.2010.146","article-title":"Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes","volume":"6","author":"Arabi","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2012.09.011_bb0195","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1359\/jbmr.080607","article-title":"Vitamin D metabolites and calcium absorption in severe vitamin D deficiency","volume":"23","author":"Need","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2012.09.011_bb0200","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1753-4887.2010.00338.x","article-title":"Relationship of calcium absorption with 25(OH)D and calcium intake in children with rickets","volume":"68","author":"Thacher","year":"2010","journal-title":"Nutr Rev"},{"key":"10.1016\/j.metabol.2012.09.011_bb0205","unstructured":"IoM Food and Nutrition Board (2011) Dietary reference intakes for calcium and vitamin D. pp. 263\u20137. The National Academies Press, Washington DC."},{"key":"10.1016\/j.metabol.2012.09.011_bb0210","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ejcn.2010.5","article-title":"Effect of age, gender and calciotropic hormones on the relationship between vitamin D receptor gene polymorphisms and bone mineral density","volume":"64","author":"Arabi","year":"2010","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.metabol.2012.09.011_bb0215","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bone.2010.05.002","article-title":"Age but not gender modulates the relationship between PTH and vitamin D","volume":"47","author":"Arabi","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2012.09.011_bb0220","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.metabol.2012.09.011_bb0225","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/j.1572-0241.2008.02031.x","article-title":"Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm","volume":"103","author":"Moayyedi","year":"2008","journal-title":"Am J Gastroenterol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512003575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512003575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:00:03Z","timestamp":1758427203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049512003575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0026049512003575"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2012.09.011","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: A prospective matched controlled study","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2012.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}